CollPlant Biotechnologies (CLGN) Assets (2016 - 2026)
CollPlant Biotechnologies (CLGN) reported Assets of $7.2 million for the quarter ended Jun 30, 2026, down 58.7% from $17.44 million a year earlier.
Powered by 
Analysis
CollPlant Biotechnologies (CLGN) Assets (2016 - 2026) Analysis & Trends
As of Dec 31, 2025, CollPlant Biotechnologies posted Assets of $10.79 million, down 42.4% from the prior year.
- Assets has declined for four consecutive years, with a five-year compound annual growth rate of -0.1% (years ended Dec 2020 to Dec 2025).
- By year, Assets came in at $18.71 million in the year ended Dec 31, 2024 (-45.2%), $34.13 million in the year ended Dec 31, 2023 (-9.6%), $37.77 million in the year ended Dec 31, 2022 (-26.3%) and $51.22 million in the year ended Dec 31, 2021 (+372.5%).
- The figure for the quarter ended Jun 30, 2026 ranks as the lowest quarterly Assets since the quarter ended Sep 30, 2018.
- The high point for year-over-year Assets in five years was the quarter ended Dec 31, 2021 (growth of 372.5%); the low point was the quarter ended Jun 30, 2026 (a decline of 58.7%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,146.94 Bn | 1,115.53 Bn | 19.71 Bn | 142.28 Bn |
| 2 | Johnson & Johnson | 624.96 Bn | 543.49 Bn | 17.26 Bn | 201.06 Bn |
| 3 | AbbVie | 510.15 Bn | 483.27 Bn | 12.70 Bn | 135.12 Bn |
| 4 | Merck | 366.13 Bn | 320.51 Bn | 12.21 Bn | 129.80 Bn |
| 5 | Novartis Ag | 297.75 Bn | 261.74 Bn | 11.24 Bn | 122.03 Bn |
| 6 | Astrazeneca | 261.93 Bn | 235.62 Bn | 12.86 Bn | 115.83 Bn |
| 7 | Amgen | 236.51 Bn | 191.91 Bn | 7.24 Bn | 95.64 Bn |
| 8 | Gilead Sciences | 194.27 Bn | 168.47 Bn | 6.22 Bn | 49.36 Bn |
| 9 | Pfizer | 171.74 Bn | 118.39 Bn | 10.94 Bn | 201.13 Bn |
| 10 | CollPlant Biotechnologies | 4.68 Mn | -17.68 Mn | -456,000.00 | 7.20 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 7.20 Mn |
| Mar 31, 2026 | 9.18 Mn |
| Dec 31, 2025 | 10.79 Mn |
| Sep 30, 2025 | 14.09 Mn |
| Jun 30, 2025 | 17.44 Mn |
| Mar 31, 2025 | 17.21 Mn |
| Dec 31, 2024 | 18.71 Mn |
| Sep 30, 2024 | 22.44 Mn |
| Jun 30, 2024 | 26.57 Mn |
| Mar 31, 2024 | 30.29 Mn |
| Dec 31, 2023 | 34.13 Mn |
| Sep 30, 2023 | 37.56 Mn |
| Jun 30, 2023 | 41.57 Mn |
| Mar 31, 2023 | 35.76 Mn |
| Dec 31, 2022 | 37.77 Mn |
| Sep 30, 2022 | 40.56 Mn |
| Jun 30, 2022 | 44.41 Mn |
| Mar 31, 2022 | 48.72 Mn |
| Dec 31, 2021 | 51.22 Mn |
| Sep 30, 2021 | 53.63 Mn |
API Access
CollPlant Biotechnologies Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=CLGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "CLGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=CLGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();